---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-022488"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2026-05-12T20:10:47+00:00"
generated_at: "2026-05-12T20:59:39.638277+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis reports Q1 revenue $6.3M, net loss $5.9M; guides FY26 rev >$40M; MAGiC FDA approved, Robocath acquisition

## Summary
- Revenue $6.3M vs $7.5M YoY; net loss $5.9M; cash $14.6M, no debt.
- MAGiC catheter (FDA approved Jan) and Synchrony system (FDA cleared Apr) now in commercial use.
- Definitive agreement to acquire Robocath, combining complementary robotic technologies.
- Guides FY26 revenue >$40M, double-digit growth; Q3 and Q4 each >$10M.
- Manufacturing ramp for MAGiC targets 500/month by year end; winding down J&J relationship.

## SEC filing metadata
- accession: 0001493152-26-022488
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2026-05-12T20:10:47+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000149315226022488/0001493152-26-022488-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000149315226022488/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-022488
- JSON: https://secwatch.observer/filing/0001493152-26-022488.json
- Plain text: https://secwatch.observer/filing/0001493152-26-022488.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.